Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 1
2007 3
2008 2
2009 7
2010 6
2011 9
2012 14
2013 14
2014 10
2015 12
2016 8
2017 9
2018 8
2019 12
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

111 results
Results by year
Filters applied: . Clear all
Page 1
Cancer immunotherapy targeting the CD47/SIRPα axis.
Weiskopf K. Weiskopf K. Eur J Cancer. 2017 May;76:100-109. doi: 10.1016/j.ejca.2017.02.013. Epub 2017 Mar 10. Eur J Cancer. 2017. PMID: 28286286 Review.
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.
Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, Direnzo D, Nanda V, Ye J, Connolly AJ, Schadt EE, Quertermous T, Betancur P, Maegdefessel L, Matic LP, Hedin U, Weissman IL, Leeper NJ. Kojima Y, et al. Nature. 2016 Aug 4;536(7614):86-90. doi: 10.1038/nature18935. Epub 2016 Jul 20. Nature. 2016. PMID: 27437576 Free PMC article.
Is CD47 an innate immune checkpoint for tumor evasion?
Liu X, Kwon H, Li Z, Fu YX. Liu X, et al. J Hematol Oncol. 2017 Jan 11;10(1):12. doi: 10.1186/s13045-016-0381-z. J Hematol Oncol. 2017. PMID: 28077173 Free PMC article. Review.
CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells.
Bruns H, Bessell C, Varela JC, Haupt C, Fang J, Pasemann S, Mackensen A, Oelke M, Schneck JP, Schütz C. Bruns H, et al. Clin Cancer Res. 2015 May 1;21(9):2075-83. doi: 10.1158/1078-0432.CCR-14-2696. Epub 2015 Jan 15. Clin Cancer Res. 2015. PMID: 25593301 Free PMC article.
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors.
Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, Xu H, Peng H, Fu YX, Xu MM. Liu X, et al. Nat Med. 2015 Oct;21(10):1209-15. doi: 10.1038/nm.3931. Epub 2015 Aug 31. Nat Med. 2015. PMID: 26322579 Free PMC article.
111 results
Jump to page
Feedback